Welcome

The Vermont Center on Behavior and Health (VCBH), led by Director Stephen T. Higgins, PhD, is an interdisciplinary research center committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death. Our work has historically focused on health disparities for the most vulnerable populations, particularly among the socioeconomically disadvantaged where these risk factors are overrepresented.

 

VCBH logo

Located in Burlington, VT at the University of Vermont, Larner College of Medicine, VCBH researchers have a specific focus on understanding mechanisms underpinning risk and developing effective interventions and policies to promote healthy behavior. A common thread across VCBH research projects is the application of knowledge from the disciplines of behavioral economics and behavioral pharmacology to increase understanding of vulnerability to unhealthy behavior and the use of incentives and other behavioral and pharmacological interventions to support healthy behavior change interventions and policies.

Stay Connected with VCBH

Join our mailing list to get the latest
on news and events.

Follow us on our social media channels

Twitter icon circle Facebook icon circle LinkedIn icon YouTube Icon

Upcoming VCBH Events


Monthly Lecture Series:
Returning on September 17, 2025

Annual Conference:
October 9-10, 2025

Visit the Center on Rural Addiction

CORA_transparents

 


VCBH Career Opportunities

None at the current time. Please check back later!

VCBH News

  • More States Looking at COVID-19 Vaccine Incentive Programs
    As the US begins to see demand for COVID-19 vaccines plateau, some states have started implementing incentive programs to encourage residents to get one of the three vaccines available: Pfizer, Moderna, or Johnson & Johnson. Recently announced incentive programs are supported by numerous research studies that support the efficacy of incentivizing vaccine adherence.
  • Biden-Harris Administration Announce Drug Policy Priorities Including Focus on Contingency Management and Reimbursement
    On April 1st, the White House Office of National Drug Control Policy (ONDCP) announced the Biden-Harris Administration’s drug policy priorities (PDF) for year one. Priority one is an expansion of access to evidence-based treatment, which includes identifying and addressing “policy barriers related to contingency management interventions (motivational incentives) for stimulant use disorder” as well as exploring “reimbursement for motivational incentives and digital treatment for addiction, especially stimulant use disorder.”
  • New Commentary on Contingency Management Published in JAMA Psychiatry
    On March 3, 2021, JAMA Psychiatry published "Bringing Together Behavioral Science, Community Engagement, and Cultural Adaptations to Increase Alcohol Abstinence Among American Indian and Alaska Native People Using Contingency Management Therapy," authored by Stephanie S. O’Malley, PhD; Maria C. Crouch, MS; Stephen T. Higgins, PhD.
  • Dr. Khadanga Talks Pandemic Side Effect: Sitting
    Sherrie Khadanga, MD, a COBRE project director at the Vermont Center on Behavior and Health, cardiologist at the University of Vermont Medical Center, and assistant professor at UVM Larner College of Medicine was interviewed for “The Pandemic’s Heart-Breaking Side Effect: Sitting, Sitting, Sitting,”
  • Brian Sprague, MD Discusses Latest Cancer Statistics
    Dr. Brian Sprague, Director of the Vermont Breast Cancer Surveillance System and Associate Professor of Surgery at the Larner College of Medicine, University of Vermont and Senior Epidemiologist at the Vermont Center on Behavior and Health discussed the latest American Cancer Society findings with local TV network WCAX.